Table 3.
The tumor inhibition rates of the treated groups (mean ± SD, n=3)
| Samples | Tumor inhibition rate (%) |
|---|---|
| HA-DOX/GA-LPHNs | 77.7±3.2 |
| DOX/GA-LPHNs | 61.1±2.1 |
| HA-DOX-LPHNs | 51.4±2.6 |
| HA-GA-LPHNs | 34.0±1.8 |
| Free DOX/GA | 27.3±1.5 |
The tumor inhibition rates of the treated groups (mean ± SD, n=3)
| Samples | Tumor inhibition rate (%) |
|---|---|
| HA-DOX/GA-LPHNs | 77.7±3.2 |
| DOX/GA-LPHNs | 61.1±2.1 |
| HA-DOX-LPHNs | 51.4±2.6 |
| HA-GA-LPHNs | 34.0±1.8 |
| Free DOX/GA | 27.3±1.5 |